These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25992589)

  • 1. GREM1 germline mutation screening in Ashkenazi Jewish patients with familial colorectal cancer.
    Laitman Y; Jaeger E; Katz L; Tomlinson I; Friedman E
    Genet Res (Camb); 2015 May; 97():e11. PubMed ID: 25992589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel GREM1 duplication in a patient with multiple colon polyps.
    McKenna DB; Van Den Akker J; Zhou AY; Ryan L; Leon A; O'Connor R; Shah PD; Rustgi AK; Katona BW
    Fam Cancer; 2019 Jan; 18(1):63-66. PubMed ID: 29804199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features of Patients With Hereditary Mixed Polyposis Syndrome Caused by Duplication of GREM1 and Implications for Screening and Surveillance.
    Lieberman S; Walsh T; Schechter M; Adar T; Goldin E; Beeri R; Sharon N; Baris H; Ben Avi L; Half E; Lerer I; Shirts BH; Pritchard CC; Tomlinson I; King MC; Levy-Lahad E; Peretz T; Goldberg Y
    Gastroenterology; 2017 Jun; 152(8):1876-1880.e1. PubMed ID: 28242209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
    Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
    Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
    Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
    Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the polyposis/colorectal cancer phenotype associated with the Ashkenazi GREM1 duplication: counselling and management recommendations.
    Ziai J; Matloff E; Choi J; Kombo N; Materin M; Bale AE
    Genet Res (Camb); 2016 Mar; 98():e5. PubMed ID: 26947005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A636P is associated with early-onset colon cancer in Ashkenazi Jews.
    Guillem JG; Rapaport BS; Kirchhoff T; Kolachana P; Nafa K; Glogowski E; Finch R; Huang H; Foulkes WD; Markowitz A; Ellis NA; Offit K
    J Am Coll Surg; 2003 Feb; 196(2):222-5. PubMed ID: 12595050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer.
    Yao ZG; Lv BB; Jing HY; Su WJ; Li JM; Fan H; Zhao MQ; Qin YJ; Sun XC
    J Cancer Res Ther; 2021 Jul; 17(3):790-796. PubMed ID: 34269315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline Mutations in the Polyposis-Associated Genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 Are Not Common in Individuals with Serrated Polyposis Syndrome.
    Clendenning M; Young JP; Walsh MD; Woodall S; Arnold J; Jenkins M; Win AK; Hopper JL; Sweet K; Gallinger S; Rosty C; Parry S; Buchanan DD
    PLoS One; 2013; 8(6):e66705. PubMed ID: 23805267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer.
    Laitman Y; Herskovitz L; Golan T; Kaufman B; Paluch SS; Friedman E
    Fam Cancer; 2012 Jun; 11(2):243-7. PubMed ID: 22219001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features of a kindred with SCG5-GREM1-associated hereditary mixed polyposis syndrome.
    Plesec T; Brown K; Allen C; A Burke C; Church J; Kalady M; LaGuardia L; O'Malley M; Heald B
    Hum Pathol; 2017 Feb; 60():75-81. PubMed ID: 27984123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
    J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas.
    Belhadj S; Quintana I; Mur P; Munoz-Torres PM; Alonso MH; Navarro M; Terradas M; Piñol V; Brunet J; Moreno V; Lázaro C; Capellá G; Valle L
    Sci Rep; 2019 Jun; 9(1):9020. PubMed ID: 31227763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.
    Mukherjee B; Rennert G; Ahn J; Dishon S; Lejbkowicz F; Rennert HS; Shiovitz S; Moreno V; Gruber SB
    Gastroenterology; 2011 Jun; 140(7):1919-26. PubMed ID: 21419771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
    Kravochuck SE; Church JM
    ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patients.
    Bernstein-Molho R; Laitman Y; Schayek H; Iomdin S; Friedman E
    Cancer Causes Control; 2019 Jan; 30(1):97-101. PubMed ID: 30498870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
    Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
    Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of hereditary non-polyposis syndrome (Lynch syndrome)].
    Kariv R; Goldberg Y; Soler I; Rosner G; Half E; Moshkowitz M; Vilkin A; Levi Z; Niv Y
    Harefuah; 2011 Apr; 150(4):392-6, 416. PubMed ID: 22164924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
    Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
    Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
    N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.